1. Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer
   Argyris Tzouvelekis et al, 2019, Chest CrossRef
2. Idiopathic pulmonary fibrosis and lung cancer
   Katerina M. Antoniou et al, 2015, Current Opinion in Pulmonary Medicine CrossRef
3. MicroRNA-21 Regulates hTERT via PTEN in Hypertrophic Scar Fibroblasts
   Hua-Yu Zhu et al, 2014, PLoS ONE CrossRef
4. miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns
   Eleni Bibaki et al, 2018, Molecular Medicine Reports CrossRef
5. Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?
   Sara Lettieri et al, 2021, International Journal of Molecular Sciences CrossRef
6. Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy
   Ofer Rotem et al, 2023, Biomedicines CrossRef
7. Cancer
   Carlo Vancheri, 2016, Idiopathic Pulmonary Fibrosis CrossRef
8. Sparse modelling of cancer patients’ survival based on genomic copy number alterations
   Khaled Alqahtani et al, 2022, Journal of Biomedical Informatics CrossRef
9. Extracellular matrix proteins produced by stromal cells in idiopathic pulmonary fibrosis and lung adenocarcinoma
   Mervi Kreus et al, 2021, PLOS ONE CrossRef
10. The role of Endoplasmic Reticulum (ER) stress in pulmonary fibrosis
    Martina Korfei et al, 2016, Endoplasmic Reticulum Stress in Diseases CrossRef
11. Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis
    Joseph Kelich et al, 2022, Journal of Experimental Medicine CrossRef
12. Idiopathic pulmonary fibrosis and cancer: do they really look similar?
    Carlo Vancheri, 2015, BMC Medicine CrossRef
13. Molecular Endotyping of Pulmonary Fibrosis
    Amanda T. Goodwin et al, 2016, Chest CrossRef
14. Lung cancer in patients with idiopathic pulmonary fibrosis
    Theodoros Karampitsakos et al, 2017, Pulmonary Pharmacology & Therapeutics CrossRef
15. Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis?
    Deborah L. Clarke et al, 2017, Pharmacology & Therapeutics CrossRef
16. Evaluation of Desmin, α-SMA and hTERT expression in pulmonary fibrosis and lung cancer
    F Fallahian, 2018, Journal of Clinical Intensive Care and Medicine CrossRef
17. PAX5 activates telomerase activity and proliferation in keloid fibroblasts by transcriptional regulation of SND1, thus promoting keloid growth in burn-injured skin
    Gaoping Qin et al, 2021, Inflammation Research CrossRef
18. Differential immunohistochemical expression of hTERT in lung cancer patients with and without idiopathic pulmonary fibrosis
    G. Gomatou et al, 2024, Pulmonology CrossRef
19. Different TERT Expression between Colorectal Adenoma and Serrated Polyp
    Soo-Jung Jung et al, 2020, Medicina CrossRef